Back to search

National and Kapodistrian University of Athens

Διερεύνηση της συχνότητας των διαταραχών έκκρισης της αλδοστερόνης σε νέο-διαγνωσμένους υπερτασικούς ασθενείς: αξιολόγηση της ανταπόκρισης των υπερτασικών ασθενών με πρωτοπαθή υπεραλδοστερονισμό στην χορήγηση στοχευμένης αγωγής με ανταγωνιστές των υποδοχέων της αλδοστερόνης

Abstract

dc:description

Background: Primary aldosteronism (PA) is the most common endocrine cause of arterial hypertension. Despite the increasing incidence of hypertension worldwide, the true prevalence of PA in hypertension was only recently recognized.Objective: To estimate the prevalence of PA in patients at different stages of hypertension based on a newly developed screening-diagnostic overnight test.Design: Prospective study. Subjects: Hypertensive patients (n=265) at stage I (n=100), II (n= 88) and III (n=77) of hypertension. A group of 103 patients with essential hypertension without PA was used as controls.Methods: PA diagnosis was based on a combined screening-diagnostic overnight test, the Dexamethasone-Captopril-Valsartan Test (DCVT) that evaluates aldosterone secretion after pharmaceutical blockade of angiotensin-II and adrenocorticotropic hormone. DCVT was performed in all participants independently of the basal aldosterone to renin ratio (ARR). Results: The calculated upper normal limits for post-DCVT aldosterone levels [3ng/dl (85 pmol/l)] and post-DCVT ARR [0.32 ng/dl/μU/ml (9pmol/IU)] from controls, were applied together to establish PA diagnosis. Using these criteria PA was confirmed in 80 of 265 (30%) hypertensives. The prevalence of PA was: 21% (21/100) in stage I, 33% (29/88) in stage II, and 39% (30/77) in stage III. Serum K+ levels were negatively correlated and urinary K+ was positively correlated in PA patients with post-DCVT ARR (r=-0.349, p<0.01, and r=0.27, p<0.05 respectively).Conclusion: DCVT revealed that PA is a highly prevalent cause of hypertension. DCVT could be employed as a diagnostic tool in all subjects with arterial hypertension of unknown cause.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Voulgaris, Nikolaos
  • Βούλγαρης, Νικόλαος

Subjects

dc:subject × 19

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/52642

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Voulgaris, Nikolaos; Βούλγαρης, Νικόλαος. Διερεύνηση της συχνότητας των διαταραχών έκκρισης της αλδοστερόνης σε νέο-διαγνωσμένους υπερτασικούς ασθενείς: αξιολόγηση της ανταπόκρισης των υπερτασικών ασθενών με πρωτοπαθή υπεραλδοστερονισμό στην χορήγηση στοχευμένης αγωγής με ανταγωνιστές των υποδοχέων της αλδοστερόνης. National and Kapodistrian University of Athens, 2022. http://hdl.handle.net/10442/hedi/52642